COMMUNIQUÉS West-GlobeNewswire

-
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
17/04/2025 - 07:00 -
Best Probiotics For Bloating: Do Probiotics Help With Bloating? Read YourBiology Reviews
17/04/2025 - 07:01 -
Pelvic Floor Strong Reviews: Effective Pelvic Floor Strong Exercises Program - See Alex Miller Exercises Program!
17/04/2025 - 08:22 -
Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives
17/04/2025 - 03:20 -
Best Anabolic Steroids (2025) – Top Oral Steroids for Massive Size & Strength! ( Get Big Quick!) - Legal Steroid - By CrazyBulk in USA
17/04/2025 - 04:15 -
Best Steroids for Beginners Bulking and Cutting: Safest Steroids for Bodybuilding - First Steroid Cycle for Bodybuilders Starting Out - CrazyBulk
17/04/2025 - 04:59 -
HepatoBurn Reviews: The Mysterious Red Phenol Formula for Metabolism Support
17/04/2025 - 05:27 -
Java Burn Under Review - The Best Healthy Coffee Option for Weight Managementcument
17/04/2025 - 05:47 -
Teladoc Health to Announce First Quarter 2025 Financial Results
17/04/2025 - 00:00 -
Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis
16/04/2025 - 20:12 -
Eascra Biotech Preparing for a Fifth Flight to the International Space Station
16/04/2025 - 21:30 -
Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)
16/04/2025 - 22:04 -
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
16/04/2025 - 22:05 -
Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires
16/04/2025 - 22:05 -
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
16/04/2025 - 22:05 -
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/04/2025 - 22:05 -
Outset Medical to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
16/04/2025 - 22:32 -
Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease
16/04/2025 - 22:44 -
FOXO TECHNOLOGIES INC. ANNOUNCES FILING OF ITS ANNUAL REPORT ON FORM 10-K
16/04/2025 - 23:45
Pages